{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:45:10Z","timestamp":1791434710297,"version":"4.3.3"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T00:00:00Z","timestamp":1454976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0148839","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T18:39:16Z","timestamp":1455043156000},"page":"e0148839","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":74,"title":["Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington\u2019s Disease"],"prefix":"10.1371","volume":"11","author":[{"given":"Qi","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mali","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhen","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,2,9]]},"reference":[{"issue":"18","key":"ref1","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1111\/febs.12418","article-title":"Genetic manipulations of mutant huntingtin in mice: new insights into Huntington&apos;s disease pathogenesis","volume":"280","author":"CY Lee","year":"2013","journal-title":"The FEBS journal"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington&apos;s disease: zQ175","volume":"7","author":"LB Menalled","year":"2012","journal-title":"PloS one"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington&apos;s disease","volume":"7","author":"T Heikkinen","year":"2012","journal-title":"PloS one"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"SW Provencher","year":"1993","journal-title":"Magn Reson Med"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/nbm.698","article-title":"Automatic quantitation of localized in vivo 1H spectra with LCModel","volume":"14","author":"SW Provencher","year":"2001","journal-title":"NMR Biomed"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/jmri.20285","article-title":"In vivo measurements of T1 relaxation times in mouse brain associated with different modes of systemic administration of manganese chloride","volume":"21","author":"YT Kuo","year":"2005","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"e4962","DOI":"10.1371\/journal.pone.0004962","article-title":"Neuroendocrine disturbances in Huntington&apos;s disease","volume":"4","author":"N Saleh","year":"2009","journal-title":"PLoS One"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1073\/pnas.0609833104","article-title":"Selective defect of in vivo glycolysis in early Huntington&apos;s disease striatum","volume":"104","author":"WJ Powers","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington&apos;s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"JG Hodgson","year":"1999","journal-title":"Neuron"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7327","article-title":"Decrease in striatal enkephalin mRNA in mouse models of Huntington&apos;s disease","volume":"162","author":"L Menalled","year":"2000","journal-title":"Experimental neurology"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","article-title":"Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice","volume":"9","author":"VC Wheeler","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"18","key":"ref12","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1523\/JNEUROSCI.22-18-08266.2002","article-title":"Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington&apos;s disease knock-in mice","volume":"22","author":"LB Menalled","year":"2002","journal-title":"J Neurosci"},{"issue":"13","key":"ref13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"EJ Slow","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"24","key":"ref14","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/hmg\/ddi407","article-title":"Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease","volume":"14","author":"JM Van Raamsdonk","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"Pt 1","key":"ref15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/brain\/awq280","article-title":"Smaller intracranial volume in prodromal Huntington&apos;s disease: evidence for abnormal neurodevelopment","volume":"134","author":"PC Nopoulos","year":"2011","journal-title":"Brain: a journal of neurology"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuroimage.2008.02.019","article-title":"Cortical thickness measured from MRI in the YAC128 mouse model of Huntington&apos;s disease","volume":"41","author":"JP Lerch","year":"2008","journal-title":"NeuroImage"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuroimage.2007.08.033","article-title":"Automated deformation analysis in the YAC128 Huntington disease mouse model","volume":"39","author":"JP Lerch","year":"2008","journal-title":"NeuroImage"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1093\/hmg\/ddv016","article-title":"Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington&apos;s disease","volume":"24","author":"J Jin","year":"2015","journal-title":"Human molecular genetics"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1212\/WNL.57.6.1025","article-title":"Striatal volume loss in HD as measured by MRI and the influence of CAG repeat","volume":"57","author":"HD Rosas","year":"2001","journal-title":"Neurology"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1212\/WNL.0000000000000187","article-title":"PRECREST: A phase II prevention and biomarker trial of creatine in at-risk Huntington disease","volume":"82","author":"HD Rosas","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1212\/WNL.53.4.806","article-title":"Clinical correlation of striatal 1H MRS changes in Huntington&apos;s disease","volume":"53","author":"R Sanchez-Pernaute","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainres.2004.10.030","article-title":"Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington&apos;s disease","volume":"1031","author":"NC Reynolds Jr.","year":"2005","journal-title":"Brain research"},{"issue":"19","key":"ref23","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.0b013e3181fc27e4","article-title":"Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease","volume":"75","author":"A Sturrock","year":"2010","journal-title":"Neurology"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1007\/s00415-011-6099-5","article-title":"Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington&apos;s disease provides in vivo evidence for impaired energy metabolism","volume":"258","author":"SJ van den Bogaard","year":"2011","journal-title":"Journal of neurology"},{"issue":"17","key":"ref25","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1097\/00001756-200011270-00032","article-title":"N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington&apos;s disease mice","volume":"11","author":"A van Dellen","year":"2000","journal-title":"Neuroreport"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1471-4159.2005.03411.x","article-title":"Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington&apos;s disease","volume":"95","author":"BG Jenkins","year":"2005","journal-title":"Journal of neurochemistry"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/mds.25010","article-title":"Brain metabolite alterations and cognitive dysfunction in early Huntington&apos;s disease","volume":"27","author":"PG Unschuld","year":"2012","journal-title":"Mov Disord"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/archneur.1986.00520120056016","article-title":"Cerebral cation shifts and amino acids in Huntington&apos;s disease","volume":"43","author":"JB Gramsbergen","year":"1986","journal-title":"Arch Neurol"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/jcbfm.2011.157","article-title":"Cortical metabolites as biomarkers in the R6\/2 model of Huntington&apos;s disease","volume":"32","author":"L Zacharoff","year":"2012","journal-title":"Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/jcbfm.2012.104","article-title":"Homeostatic adaptations in brain energy metabolism in mouse models of Huntington disease","volume":"32","author":"I Tkac","year":"2012","journal-title":"Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"issue":"5334","key":"ref31","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"M DiFiglia","year":"1997","journal-title":"Science"},{"issue":"7","key":"ref32","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington&apos;s disease: relationship to neuropathology","volume":"19","author":"CA Gutekunst","year":"1999","journal-title":"J Neurosci"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","article-title":"Huntington aggregates may not predict neuronal death in Huntington&apos;s disease","volume":"46","author":"S Kuemmerle","year":"1999","journal-title":"Ann Neurol"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ana.410300406","article-title":"Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington&apos;s disease: an in situ hybridization study","volume":"30","author":"RL Albin","year":"1991","journal-title":"Annals of neurology"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.410420213","article-title":"Dopamine D1 and D2 receptor gene expression in the striatum in Huntington&apos;s disease","volume":"42","author":"SJ Augood","year":"1997","journal-title":"Annals of neurology"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington&apos;s disease mice","volume":"97","author":"JA Bibb","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"17","key":"ref37","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/hmg\/11.17.1939","article-title":"Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington&apos;s disease","volume":"11","author":"EY Chan","year":"2002","journal-title":"Human molecular genetics"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0306-4522(00)00157-3","article-title":"Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington&apos;s disease mice","volume":"98","author":"EM Denovan-Wright","year":"2000","journal-title":"Neuroscience"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuroscience.2003.11.009","article-title":"Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington&apos;s disease transgenic mice prior to the onset of motor symptoms","volume":"123","author":"AL Hebb","year":"2004","journal-title":"Neuroscience"},{"issue":"12","key":"ref40","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1111\/j.1460-9568.2004.03796.x","article-title":"Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A","volume":"20","author":"H Hu","year":"2004","journal-title":"The European journal of neuroscience"},{"issue":"9","key":"ref41","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington&apos;s disease","volume":"9","author":"R Luthi-Carter","year":"2000","journal-title":"Human molecular genetics"},{"issue":"23\u201324","key":"ref42","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/j.1432-1033.2004.04460.x","article-title":"Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington&apos;s disease transgenic mice","volume":"271","author":"EA McCaw","year":"2004","journal-title":"European journal of biochemistry \/ FEBS"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ana.410370309","article-title":"Reduced expression of preproenkephalin in striatal neurons from Huntington&apos;s disease patients","volume":"37","author":"EK Richfield","year":"1995","journal-title":"Annals of neurology"},{"issue":"9","key":"ref44","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1523\/JNEUROSCI.1658-03.2004","article-title":"Environmental enrichment rescues protein deficits in a mouse model of Huntington&apos;s disease, indicating a possible disease mechanism","volume":"24","author":"TL Spires","year":"2004","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nbd.2007.11.006","article-title":"Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington&apos;s disease transgenic mice","volume":"29","author":"J Nithianantharajah","year":"2008","journal-title":"Neurobiology of disease"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0148839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T03:20:45Z","timestamp":1588994445000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0148839"}},"subtitle":[],"editor":[{"given":"Sandrine","family":"Humbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,9]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0148839","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,9]]}}}